Jenny Graffato
Family · Metairie, LANPI 1932770880
Payments from drug & device makers
Across 142 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$570
- Teva Pharmaceuticals USA, Inc.$551
- Alkermes, Inc.$355
- Otsuka America Pharmaceutical, Inc.$313
- AbbVie$196
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$181
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,460100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 22 | $570 |
| Teva Pharmaceuticals USA, Inc. | 31 | $551 |
| Alkermes, Inc. | 19 | $355 |
| Otsuka America Pharmaceutical, Inc. | 18 | $313 |
| AbbVie | 4 | $196 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $181 |
| Dexcom, Inc. | 1 | $163 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Lundbeck LLC | 9 | $144 |
| Neurocrine Biosciences, Inc. | 5 | $136 |
| Novo Nordisk | 1 | $124 |
| Neurelis, Inc. | 1 | $124 |
| Actelion Pharmaceuticals US, Inc. | 1 | $118 |
| Amgen | 1 | $114 |
| Lilly USA, LLC | 1 | $95 |
| Indivior Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $18 |
| Exact Sciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$163
- DEXCOM STELO GLUCOSE BIOSENSOR$163
- REZDIFFRA$147
- Humira$125
- Wegovy$124
- VALTOCO$124
- Austedo XR$122
- UPTRAVI$118
- OPSUMIT$118
- KRYSTEXXA$114
- SPRAVATO$109
How this compares
$3,460 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 22 | $310 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $242 |
| Losartan Potassium | 18 | $159 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $101 |
| Levothyroxine Sodium | 14 | $82 |
| Atorvastatin Calcium | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Other family in Metairie
- Tara RiceMetairie$15K
- Brittany BadingerMetairie$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.